Wei Niu

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Yongkun Sun, Wei Niu, Feng Du et al. · Journal of Hematology & Oncology · 2016 · 431 citations · Full text

Medicine, Oncology, Pharmacology +15

Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats

Houfu Liu, Junling Yang, Feifei Du et al. · Drug Metabolism and Disposition · 2009 · 355 citations

Medicine, Pharmacokinetics, Pharmacology +10

Kuijieyuan Decoction Improved Intestinal Barrier Injury of Ulcerative Colitis by Affecting TLR4-Dependent PI3K/AKT/NF-κB Oxidative and Inflammatory Signaling and Gut Microbiota

Baohai Liu, Xuehua Piao, Wei Niu et al. · Frontiers in Pharmacology · 2020 · 154 citations · Full text

Life Sciences, Immunology, Pharmacology +17

NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model

James C. Cusack, Rong Liu, Lijun Xia et al. · Clinical Cancer Research · 2006 · 91 citations

Medicine, Oncology, Pharmacology +14

Combinatorial Metabolism Notably Affects Human Systemic Exposure to Ginsenosides from Orally Administered Extract of Panax notoginseng Roots (Sanqi)

Zheyi Hu, Junling Yang, Chen Cheng et al. · Drug Metabolism and Disposition · 2013 · 70 citations

Pharmacy, Pharmacokinetics, Pharmacology +11